CSIMarket
 


Hutchmed china Limited  (HCM)
Other Ticker:  
 

Cumulative Hutchmed China Limited's Total Debt to Equity for Trailing Twelve Months Period

HCM's Total Debt to Equity for Trailing Twelve Months Period and Total Debt, Equity growth


Select the Comparisons : Select the Ratio:

HCM Total Debt to Equity for Trailing Twelve Months Period

(Dec 31 2023)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity Growth 16.73 % 16.73 % 16.73 % 16.73 % -38.73 %
Y / Y Total Debt Growth 338.27 % 338.27 % 338.27 % 338.27 % -32.71 %
Total Debt to Equity for Trailing Twelve Months Period 0.11 0.09 0.07 0.05 0.03
Total Ranking # 344 # # # # 354
Seq. Equity Growth 0 % 0 % 0 % 16.73 % 0 %
Seq. Total Debt Growth 0 % 0 % 0 % 338.27 % 0 %


Total Debt to Equity for Trailing Twelve Months Period Comment for 12 Months ending at Dec 31 2023
On the trailing twelve months basis Despite repayements of liabilities of 0% in IV. Quarter, Total Debt to Equity for Trailing Twelve Months Period improved to 0.11, a new company high.
Total Debt to Equity for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Major Pharmaceutical Preparations industry 28 other companies have achieved lower Total Debt to Equity for Trailing Twelve Months Period than Hutchmed China Limited. While total ranking remained unchanged compare to previous quarter at no. .

What is Debt to Equity Ratio?
HCM Charts and Quotes
Total Debt to Equity HCM in the most recent quarter
Total Debt to Equity for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 29
Sector # 67
S&P 500 # 344


Total Debt to Equity for Trailing Twelve Months Period Statistics
High Average Low
0.11 0.06 0.03
(Dec 31 2023)  




Companies with similar average Total Debt to Equity for Trailing Twelve Months Period for 12 months ending Dec 31 2023, within Major Pharmaceutical Preparations Industry Total Debt to Equity for Trailing Twelve Months Period
Eagle Pharmaceuticals inc   0.29 
Verrica Pharmaceuticals Inc   0.29 
Zevra Therapeutics Inc   0.29 
Xoma Corporation  0.29 
Evotec Se  0.28 
Uniqure N v   0.27 
Organogenesis Holdings Inc   0.26 
Alkermes Plc   0.26 
Unity Biotechnology Inc   0.25 
Oramed Pharmaceuticals Inc   0.25 
Werewolf Therapeutics Inc   0.25 
Oncotelic Therapeutics Inc   0.25 
Blue Water Biotech Inc   0.25 
Centessa Pharmaceuticals Plc  0.24 
Biomarin Pharmaceutical Inc  0.23 
Celularity Inc   0.23 
Assertio Holdings inc   0.23 
Legend Biotech Corporation  0.22 
Ardelyx Inc   0.22 
Savara Inc   0.22 
Geron Corp  0.22 
Vera Therapeutics Inc   0.21 
Hcw Biologics Inc   0.20 
Janone Inc   0.20 
Sanofi  0.19 
Equillium Inc   0.19 
Provention Bio Inc   0.19 
Iveric Bio Inc   0.19 
Intercure Ltd   0.19 
Qualigen Therapeutics Inc   0.19 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com